| 1. |
胃肠道间质瘤中国专家组. 胃肠道间质瘤诊断与治疗中国专家共识[J]. 中华胃肠外科杂志， 2009， 12(5)：536-539.
|
| 2. |
Fletcher CD， Berman JJ， Corless C， et al. Diagnosis of gastrointestinal stromal tumors：A consensus approach[J]. Hum Pathol， 2002， 33(5)：459-465.
|
| 3. |
Miettinen M， Blay JY， Sobin LH. Mesenchymal tumors of the stomach//Hamilton SR， Aaltonen LA， ed. World Health Organi-zation classification of tumours. Pathology and genetics oftumours of the digestive system[M]. Lyon：IARC Press， 2000：62-65.
|
| 4. |
Miettinen M， Sarlomo-Rikala M， Lasota J. Gastrointestinal stromal tumors：recent advances in understanding of their biology[J]. Hum Pathol， 1999， 30(10)：1213-1220.
|
| 5. |
DeMatteo RP， Lewis JJ， Leung D， et al. Two hundred gastrointestinal stromal tumors：recurrence patterns and prognostic factorsfor survival[J]. Ann Surg， 2000， 231(1)：51-58.
|
| 6. |
Rossi CR， Mocellin S， Mencarelli R， et al. Gastrointestinal stromal tumors：from a surgical to a molecular approach[J]. Int J Cancer， 2003， 107(2)：171-176.
|
| 7. |
Clary BM， DeMatteo RP， Lewis JJ， et al. Gastrointestinalstromal tumors and leiomyosarcoma of the abdomen and retroperitoneum：a clinical comparison[J]. Ann Surg Oncol， 2001， 8(4)：290-299.
|
| 8. |
Blay JY， BonvalotS， Casali P， et al. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004， under the auspices of ESMO[J]. Ann Oncol， 2005， 16(4)：566-578.
|
| 9. |
Plaat BE， Hollema H， Molenaar WM， et al. Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors：differences in clinical outcome and expression of multidrug resistance proteins[J]. J Clin Oncol， 2000， 18(18)：3211-3220.
|
| 10. |
Ng EH， Pollock RE， Munsell MF， et al. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging[J]. Ann Surg， 1992， 215(1)：68-77.
|
